Use of real-world evidence (RWE) in support of regulatory filings continues to be a key focus area among life sciences companies. As the field learns from regulator feedback about how RWE can meaningfully contribute to submissions, we begin to get a clearer picture of near-term opportunities for regulatory RWE. Hear from life science leaders about how their organizations have successfully applied RWE in recent regulatory submissions, as well as Flatiron’s evolving perspective on the use of RWE for regulatory use.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.